| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Drugs Made In America Acquisition Corp. | CFO | Ordinary shares | 100,000 | 29 Jan 2025 | Direct | ||
| Drugs Made In America Acquisition II Corp. | CFO | Ordinary shares | 100,000 | 26 Sep 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000121390025103204-worman-glenn-c-2025-10-28 | Insight Digital Partners II | 28 Oct 2025 | 0 | $0 | 3 | Chief Financial Officer | 28 Oct 2025, 19:09 |
| DMII | Drugs Made In America Acquisition II Corp. | 26 Sep 2025 | 1 | $0 | 4 | CFO | 01 Oct 2025, 15:49 |
| DMII | Drugs Made In America Acquisition II Corp. | 24 Sep 2025 | 0 | $0 | 3 | CFO | 24 Sep 2025, 17:43 |
| DMAA | Drugs Made In America Acquisition Corp. | 29 Jan 2025 | 1 | $0 | 4 | CFO | 03 Feb 2025, 19:21 |
| DMAA | Drugs Made In America Acquisition Corp. | 07 Jan 2025 | 0 | $0 | 3 | CFO | 10 Jan 2025, 07:42 |